Haleon PLC Logo

Haleon PLC

A global consumer healthcare company focused on improving everyday health.

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+2 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE

Description

Haleon PLC is a global consumer healthcare company focused on improving everyday health. The company develops and markets a portfolio of category-leading brands built on scientific innovation and trusted by consumers and healthcare professionals. Its product offerings span several key categories, including Oral Health, Pain Relief, Respiratory Health, and Vitamins, Minerals, and Supplements. Notable brands within its portfolio include Sensodyne, Advil, Voltaren, and Centrum. Haleon's mission is to deliver better everyday health with humanity, making it more achievable, inclusive, and sustainable.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-15 11:10
Board and Committee Changes
English 12.2 KB
2025-12-10 16:25
Director/PDMR Shareholding
English 37.9 KB
2025-12-01 11:40
Total Voting Rights and Capital
English 7.8 KB
2025-11-12 12:10
Director/PDMR Shareholding
English 38.0 KB
2025-11-10 08:25
Appointment of Vindi Banga as Chair
English 15.0 KB
2025-11-03 12:40
Total Voting Rights and Capital
English 7.8 KB
2025-10-30 08:10
Haleon 2025 Q3 Trading Statement
English 410.9 KB
2025-10-30 08:00
Haleon 2025 Q3 Trading Statement
English 14.7 KB
2025-10-10 13:45
Director/PDMR Shareholding
English 39.5 KB
2025-10-02 11:05
Director Declaration
English 6.9 KB
2025-10-02 08:00
Transaction in Own Shares & Buyback Update
English 19.2 KB
2025-10-01 11:00
Total Voting Rights and Capital
English 8.1 KB
2025-10-01 08:00
Transaction in Own Shares
English 18.0 KB
2025-09-29 08:00
Transaction in Own Shares
English 17.9 KB
2025-09-26 14:30
Director/PDMR Shareholding
English 115.8 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Haleon PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.